Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani: I will Remain Committed to the Humanitarian, National and Legal Standards

 
The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

Minister Hasbani thanked the ones who call themselves “ex-Lebanese Forces members” for the statement they delivered as it enabled him to clarify the false information they gave. The medicine bill for Palestinians covered by the Ministry in 2017 was reduced to zero after the Ministry succeeded in getting the UNRWA, the UN organizations and associations fulfill their duties. The Palestinian dialysis bill covered as well by the Ministry was also reduced by 83%, while the hospitalization cases at the expenses of the Ministry were very limited, such as the critical and emergency cases that seriously threaten the lives of patients.

First: It is not true that an amount of LBP 7.5 billion was allocated yearly for the hospitalization of Palestinian patients in Lebanon during the term of Hasbani. There are three levels: the hospitalization, medicine and dialysis bills. As for hospitalization, the cases are too limited and urgent. The medicine bill has been reduced to zero in 2017, while the dialysis bill coverage included 152 non-Palestinians and 80 Palestinians in 2016 and the Ministry has succeeded in reducing the number of non-Palestinians to 20 and that of the Palestinians to half, i.e. 40.

To sum up, a comparison between 2016 and 2017 shows that the dialysis bill of Palestinians was reduced from LBP 3.2 Billion to LBP 560 million.
Second: Helping a dying Syrian child without any official identity documents at Quarantine Hospital is considered as a humanitarian honor. Is it acceptable to let a child die for the costs of his treatment are not yet provided?!! In this context, it is worth noting that the similar cases that were covered by the Ministry in 2017 are too limited and were very critical.

Third: It is not true that an employee was punished for not admitting the Syrian patient, knowing that Health Ministry is responsible for the hospitalization of the uninsured Lebanese.
 
While some people are trying to overemphasize the humanitarian role and others are keen to the public finance, the Health Minister will remain committed to the humanitarian, national and legal standards at the same time and will not be induced into their old grudges.
    ...
    149
    ...
ATC Name B/G Ingredients Dosage Form Price
B02BD02 BERIATE BioHuman Coagulation Factor VIII - 500IU 500IU Injectable lyophilised powder for solution+diluent 28,437,886 L.L
B02BD02 OCTANATE BioHuman Coagulation Factor VIII - 500IU 500IU Injectable lyophilised powder for solution+diluent 26,495,478 L.L
B02BD02 NOVOEIGHT BioTech Turoctocog Alfa - 500IU 500IU Injectable powder for solution+diluent 29,783,973 L.L
B02BD02 NUWIQ BioTech Coagulation Factor VIII recombinant, human (Simoctogog alfa) - 500IU 500IU Injectable powder for solution+diluent 47,418,699 L.L
B02BD02 RECOFACT VIII BioTech Moroctocog alfa - 500IU 500IU Injectable powder for solution+diluent 12,049,005 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 500IU 500IU Injectable lyophilised powder for solution+diluent 23,067,288 L.L
B02BD04 OCTANINE F BioHuman Plasma coagulation factor IX, human - 500IU 500IU Injectable freeze dried powder + diluent 31,425,075 L.L
B02BD04 BENEFIX BioTech Nonacog alfa (recombinant coagulation factor IX) - 500IU 500IU Injectable powder for solution+diluent 27,390,281 L.L
B02BD04 REFIXIA BioTech Nonacog beta pegol (factor IX) - 500IU 500IU Injectable powder for solution+solvent 76,080,435 L.L
B02BD04 BENEFIX BioTech Nonacog alfa (recombinant coagulation factor IX) - 500IU 500IU Injectable powder for solution+diluent L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 500IU 500IU Injectable lyophilised powder for solution+diluent L.L
B02BD02 ESPEROCT BioTech Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 500IU/Vial 500IU/Vial Injectable powder for solution+diluent 38,126,657 L.L
B03BA01 COBAL G Vitamin B12 - 500mcg 500mcg Tablet, coated 486,471 L.L
C01CA06 PHENYLEPHRINE AGUETTANT G Phenylephrine - 500mcg/10ml 500mcg/10ml Injectable solution 11,464,796 L.L
R03BB01 ATROVENT B Ipratropium bromide - 500mcg/2ml 500mcg/2ml Inhaltion solution with nebuliser 713,580 L.L
B03BA05 COBAL G Mecobalamine - 500mcg/ml 500mcg/ml Injectable solution 1,128,828 L.L
C01EA01 PROSTIN VR B Alprostadil - 500mcg/ml 500mcg/ml Injectable concentrated solution 19,894,577 L.L
C02AB02 ALDOMET B Methyldopa - 500mg 500mg Tablet, coated 856,708 L.L
J01FA09 KLACID RM B Clarithromycin - 500mg 500mg Tablet, modified release 1,173,175 L.L
L01XX05 CUREAML G Hydroxycarbamide (or Hydroxyurea) - 500mg 500mg Capsule 1,228,272 L.L
L01XX05 CYTODROX G Hydroxycarbamide (or Hydroxyurea) - 500mg 500mg Capsule 3,301,821 L.L
L01XX05 UNIDREA G Hydroxycarbamide (or Hydroxyurea) - 500mg 500mg Capsule, hard 2,539,862 L.L
L04AA06 IMUNOCELL G Mycophenolate mofetil - 500mg 500mg Tablet, film coated L.L
J01FA10 ARATRO G Azithromycin - 500mg 500mg Tablet, film coated 485,127 L.L
J01FA10 AZICIN 500 BENTA G Azithromycin - 500mg 500mg Tablet, film coated 573,373 L.L
J01FA10 AZM-500 G Azithromycin - 500mg 500mg Tablet, film coated 448,843 L.L
J01FA10 ZITHROFORTE G Azithromycin (dihydrate) - 500mg 500mg Tablet, film coated 485,127 L.L
N03AG01 DEPAKINE B Sodium Valproate - 500mg 500mg Tablet, enteric coated 479,752 L.L
N01AF03 THIOPENTAL PANPHARMA G Thiopental - 500mg 500mg Injectable powder for solution 8,446,717 L.L
N03AG01 DEPAKINE CHRONO B Valproic acid - 145mg, Sodium Valproate - 333mg 500mg Tablet, coated, scored, prolonged release 362,837 L.L
    ...
    149
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025